Albumin distribution

Figure 12.6. Fluorescein-labelled aconylated human serum albumin distribution in the cross-section of a rat liver slice ( 250 jrM) after 120 min incubation. Bar = 100 [xM.

Pharmacokinetics Well absorbed from G1 tract. Protein binding 97%. Principally bound to albumin. Distributed into cerebrospinal fluid. Metabolized in the liver. Undergoes extensive first-pass effect. Excreted in urine and feces. Half-life 19-37 hr. 

Concerning the distribution of a drug, models have been published for log BB blood/brain partition coefficient) for CNS-active drugs (CNS, central nervous system) crossing the blood-brain barrier (BBB) [38-45] and binding to human serum albumin (HSA) [46]. 

Data from a single study in dogs suggest that hepatic first-pass metabolism may limit systemic availability of the parent compound following oral exposure (Braeckman et al. 1983). Placental transfer of methyl parathion was demonstrated in pregnant rats 1-3 days before parturition. Thirty minutes after administration, both methyl parathion and methyl paraoxon were found in fetal brain, liver, and muscle methyl parathion, but not methyl paraoxon, was detected in placenta and maternal liver (Ackermann and Engst 1970). Methyl parathion binds reversibly to serum albumin, but is readily distributed to the tissues (Braeckman et al. 1980, 1983). 

FIGURE 5.3 Continued) (b) Distribution of modified Rankin Scale (mRS) scores at 3 months in the lower (I-III) and higher (IV-VI) albumin dose tiers for the rt-PA and non-rt-PA cohorts. (Reprinted with permission from reference 57.)... 

Aqueous solubility is not usually considered a priori as a problem in the drug discovery of acidic compounds. More important issues are (i) the high serum albumin binding of stronger acids, (ii) the very low or nonexistent central nervous system penetration of stronger acids, (iii) the low volumes of distribution of acids limiting these mostly to plasma compartment targets, (iv) the possibility of formation of... 

Hollosy, F., Valko, K., Hersey, A., Nunhuck, S., Keri, G., Bevan, C. Estimation of volume of distribution in humans from high throughput HPLC-based measurements of human serum albumin binding and immobilized artificial membrane partitioning. J. Med. Chem. 2006, 49, 6958-6971. 

Generally, the major adverse effects associated with colloids are fluid overload, dilutional coagulopathy, and anaphy-lactoid/anaphylactic reactions.24,32 Although derived from pooled human plasma, there is no risk of disease transmission from commercially available albumin or PPF products since they are heated and sterilized by ultrafiltration prior to distribution.24 Because of direct effects on the coagulation system with the hydroxyethyl starch and dextran products, they should be used cautiously in hemorrhagic shock patients. This is another reason why crystalloids maybe preferred in hemorrhagic shock. Furthermore, hetastarch can result in an increase in amylase not associated with pancreatitis. As such, the adverse-effect profiles of the various fluid types should also be considered when selecting a resuscitation fluid. 

Preparation of nanoparticles can be by a variety of different ways. The most important and frequently used is emulsion polymerization others include interfacial polymerization, solvent evaporation, and desolvation of natural proteins. The materials used to prepare nanoparticles are also numerous, but most commonly they are polymers such as poly-alklcyanoacrylate, polymethylmethacrylate, poly-butylcyanoacrylate, or are albumin or gelatin. Distribution patterns of the particles in the body can vary depending on their size, composition, and surface charge [83-85]. In particular, nanoparticles of polycyanoacrylate have been found to accumulate in certain tumors [86,87]. 

AC ADME ANS AUC BA/BE BBB BBM BBLM BCS BLM BSA CE CHO CMC CPC CPZ CTAB CV DA DOPC DPPC DPPH aminocoumarin absorption, distribution, metabolism, excretion anilinonaphthalenesulfonic acid area under the curve bioavailability-bioequivalence blood-brain barrier brush-border membrane brush-border lipid membrane biopharmaceutics classification system black lipid membrane bovine serum albumin capillary electrophoresis caroboxaldehyde critical micelle concentration centrifugal partition chromatography chlorpromazine cetyltrimethylammonium bromide cyclic votammetry dodecylcarboxylic acid dioleylphosphatidylcholine dipalmitoylphosphatidylcholine diphenylpicrylhydrazyl... 

Distribution. Lead in blood partitions between plasma and red blood cells, with the larger fraction (90-99%) associated with red blood cells (Cake et al. 1996 DeSilva 1981 Everson and Patterson 1980 Manton and Cook 1984 Ong and Lee 1980a). Lead in plasma binds to albumin and y -globulins (Ong and Lee 1980a). The fraction that is not bound to protein exists largely as complexes with low molecular weight sulfhydryl compounds these may include cysteine, homocysteine, and cysteamine (Al-Modhefer et al. 1991). Approximately 75% was bound to protein when whole human blood was incubated with 50 ig/dL lead (as lead chloride) approximately 90% of the bound lead was associated with albumin (Ong and Lee 1980a). However, the fraction of lead in plasma bound to protein would be expected to vary with the plasma lead concentration. 

Curry, S., Mandelkow, H., Brick, P. and Franks, N. (1998) Crystal structure of human serum albumin complexed with fatty acid reveals an asymmetric distribution of binding sites. Nature Structural Biology 5, 827-835. 

---